ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Allos Therapeutics


Include trials that are no longer recruiting patients.

4 studies were found.
1.No longer recruitingChemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; ...
2.No longer recruitingCombination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
3.No longer recruitingRadiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
Condition: brain metastases
4.RecruitingStandard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer
Conditions: Breast Cancer; Metastases

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act